1 |
0.01 µg Ag/mL |
24 h |
20, 50, 75 |
Human pulmonary epithelial cell line 16HBE14 |
Dose and process of uptake |
[137] |
2 |
c0/4 and higher, 2.25 × 109–1.35 × 1010 Wrs/mL, 9 × 1015–1.01 × 1016 nm²/mL, 3.68–3.83 mg/mL |
24 h |
30, 60–100 |
Human alveolar epithelial cells (A549) |
Spherical particles had no effect than silver wires |
[38] |
3 |
30 and 278 ng/cm2
|
4 and 24 h |
20 |
Human alveolar epithelial cells (A549) |
Cells were only sensitive to high Ag-ion concentrations |
[138] |
4 |
20 and 100 µg/mL |
48 h |
10, 20, 75 and 110 |
T84 cells (ATCC CCL-248™), a human colorectal carcinoma cell line |
Small AgNPs have significant effects on intestinal permeability |
[139] |
5 |
50 mg/L |
24 h |
61.2 ± 33.9 |
Porcine kidney (Pk15) cells |
AgNPs had only insignificant toxicity at concentrations lower than 25 mg/L, whereas Ag+ exhibited a significant decrease in cell viability at higher concentration |
[140] |
6 |
2–6 μM |
1–3 weeks |
20–60 |
Human HCE-T corneal epithelial cells |
Mammalian cell toxicity was observed at high (8–12 μM silver ion) silver levels in serum-free culture |
[141] |
7 |
2–6 μM |
1–3 weeks |
20–60 |
RAW264.7 macrophages |
Low cell pro-inflammatory cytokine activation was observed |
[141] |
8 |
0.31 to 10 g/mL |
48 h |
10 |
Human tongue squamous carcinoma SCC-25 |
Reduced proliferation and viability |
[142] |
9 |
20 μg/mL |
24 h |
70 |
Alveolar epithelial cells, macrophages, and dendritic cells |
Adverse effects were also only found at high silver concentrations |
[143] |
10 |
1.0 and 2.5 μg/mL |
72 h |
35 |
Human microvascular endothelial cells |
Loss of membrane integrity at higher concentrations |
[72] |
11 |
500 nM |
24 h |
50 |
Bovine retinal endothelial cells |
Enhanced apoptosis |
[64] |
12 |
500 nM |
24 h |
50 |
Dalton’s lymphoma ascites |
Anti-tumor activity |
[144] |
13 |
2.0 and 4.0 mg/L |
24 h |
10 and 100 |
HepG2 cells |
Non-cytotoxic doses induced p38 MAPK pathway activation and led to the promotion of HepG2 cell proliferation |
[47] |
14 |
7.74 mg/L |
24–72 h |
65–69 |
HaCaT cells, |
HaCaT cells were found to be resistant |
[145] |
15 |
1.16 mg/L |
24–72 h |
65–69 |
HeLa cells |
HeLa cells were found to be more sensitive |
[145] |
16 |
1–20 μg/mL |
24 h |
23 |
Embryonic neural stem cells |
Ag-NPs-induced neurotoxicity |
[104] |
17 |
10–20 μg/mL |
24 h |
20 and 40 |
Primary mixed neural cell cultures |
Strong effects of SNP associated with calcium dysregulation and ROS formation in primary neural cells |
[24] |
18 |
5–12.50 μg/mL |
24 h |
3–5 |
Mouse brain neural cells |
AgNPs could alter gene and protein expressions of β-amyloid (Aβ) deposition |
[146] |
19 |
800 particles/cell |
48 h |
20 and 80 |
Human embryonic neural precursor Cell |
AgNPs exposure cause a significant stress response in the growing Human neural progenitor cells (hNPC) |
[147] |
20 |
5 μg/mL |
48 h |
<100 |
HT22 mouse hippocampal neuronal cells |
AgNPs modulated HT22 cell cycle , proliferation, induced oxidative stress and 53BP1 recruitment |
[148] |